» Articles » PMID: 18340424

A Highly Bone Marrow Metastatic Murine Breast Cancer Model Established Through in Vivo Selection Exhibits Enhanced Anchorage-independent Growth and Cell Migration Mediated by ICAM-1

Overview
Specialty Oncology
Date 2008 Mar 15
PMID 18340424
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

To understand the mechanisms underlying bone marrow metastasis precisely, we established the highly metastatic 4T1E/M3 murine breast cancer cell line. 4T1 murine breast cancer cells were transfected with the neomycin resistance gene, selected in G418, intravenously injected into mice, and harvested from bone marrow. By repeating this protocol three times, we established the 4T1E/M3 cells. The clonality of 4T1E/M3 cells was markedly high confirmed by genomic southern analysis using neo-gene probe. When tissues harvested from mice after intravenous injection of 4T1E/M3 cells were examined histologically, markedly enhanced bone marrow metastasis was observed; 77% of spines from 4T1E/M3-injected mouse showed metastasis as compared to 14% metastasis seen with the parent cells. In vitro, 4T1E/M3 cells attached more strongly to the plastic plate and to bone marrow-derived endothelial cells. DNA micro arrays, real time RT-PCR and FACS analyses revealed that the expression of ICAM-1 and beta2 integrin was upregulated in 4T1E/M3 cells at both the mRNA and cell surface protein levels. 4T1E/M3 cells also showed greater anchorage-independent proliferation in soft agar, and migrated markedly faster than the parent cells in wound healing assays. Anti-ICAM-1 antibodies strongly inhibited both the colony formation and the migration activity of 4T1E/M3 suggesting the importance of the role of ICAM-1. Our newly established highly metastatic 4T1E/M3 cells may provide a potentially powerful tool to study the molecular mechanisms of bone marrow metastasis and to identify new molecular targets for therapeutic interventions.

Citing Articles

The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis.

Yoshimura T, Li C, Wang Y, Matsukawa A Cell Mol Immunol. 2023; 20(7):714-738.

PMID: 37208442 PMC: 10310763. DOI: 10.1038/s41423-023-01013-0.


The Cytotoxicity of Doxorubicin Can Be Accelerated by a Combination of Hyperthermia and 5-Aminolevulinic Acid.

Kurokawa H, Matsui H Antioxidants (Basel). 2021; 10(10).

PMID: 34679666 PMC: 8532950. DOI: 10.3390/antiox10101531.


How to Target Spinal Metastasis in Experimental Research: An Overview of Currently Used Experimental Mouse Models and Future Prospects.

Jelgersma C, Vajkoczy P Int J Mol Sci. 2021; 22(11).

PMID: 34063821 PMC: 8196562. DOI: 10.3390/ijms22115420.


Scanning Electron-Assisted Dielectric Microscopy Reveals Autophagosome Formation by LC3 and ATG12 in Cultured Mammalian Cells.

Okada T, Ogura T Int J Mol Sci. 2021; 22(4).

PMID: 33673233 PMC: 7917705. DOI: 10.3390/ijms22041834.


The In Vivo Selection Method in Breast Cancer Metastasis.

Nakayama J, Han Y, Kuroiwa Y, Azuma K, Yamamoto Y, Semba K Int J Mol Sci. 2021; 22(4).

PMID: 33672831 PMC: 7918415. DOI: 10.3390/ijms22041886.


References
1.
Eckhardt B, Parker B, van Laar R, Restall C, Natoli A, Tavaria M . Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix. Mol Cancer Res. 2005; 3(1):1-13. View

2.
Lee J, Kim H, Ryu C, Kim J, Choi B, Lim Y . Merlin, a tumor suppressor, interacts with transactivation-responsive RNA-binding protein and inhibits its oncogenic activity. J Biol Chem. 2004; 279(29):30265-73. DOI: 10.1074/jbc.M312083200. View

3.
Minn A, Gupta G, Siegel P, Bos P, Shu W, Giri D . Genes that mediate breast cancer metastasis to lung. Nature. 2005; 436(7050):518-24. PMC: 1283098. DOI: 10.1038/nature03799. View

4.
Pulaski B, Clements V, Pipeling M, Ostrand-Rosenberg S . Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon gamma. Cancer Immunol Immunother. 2000; 49(1):34-45. PMC: 11037012. DOI: 10.1007/s002620050024. View

5.
Luo Y, Zhou H, Krueger J, Kaplan C, Lee S, Dolman C . Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest. 2006; 116(8):2132-2141. PMC: 1513049. DOI: 10.1172/JCI27648. View